Relay Therapeutics, Inc. Prepaid Expense and Other Assets, Current
Relay Therapeutics, Inc. (RLAY) had Prepaid Expense and Other Assets, Current of $12.75 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2022-08-04
- 2022-06-30: Prepaid Expense and Other Assets, Current $12.75M.
- 2022-03-31: Prepaid Expense and Other Assets, Current $12.66M.
- 2021-12-31: Prepaid Expense and Other Assets, Current $13.23M.
- 2021-09-30: Prepaid Expense and Other Assets, Current $17.70M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2022-06-30 | $12.75M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $12.66M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $13.23M 10-Q · filed 2022-08-04 |
| 2021-09-30 | $17.70M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.58M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $7.75M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $9.38M 10-K · filed 2022-02-24 |
| 2020-09-30 | $8.38M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.66M 10-Q · filed 2020-08-27 |
| 2019-12-31 | $4.72M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |